TR200003570T2 - Mumbaistatin, Üretim yöntemi ve farmasötik kullanımı - Google Patents

Mumbaistatin, Üretim yöntemi ve farmasötik kullanımı

Info

Publication number
TR200003570T2
TR200003570T2 TR2000/03570T TR200003570T TR200003570T2 TR 200003570 T2 TR200003570 T2 TR 200003570T2 TR 2000/03570 T TR2000/03570 T TR 2000/03570T TR 200003570 T TR200003570 T TR 200003570T TR 200003570 T2 TR200003570 T2 TR 200003570T2
Authority
TR
Turkey
Prior art keywords
mumbaistatin
production method
pharmaceutical use
dsm
pharmaceuticals
Prior art date
Application number
TR2000/03570T
Other languages
English (en)
Inventor
Satya Ramakrishna Nirogi Venkata
Hosamane Sreedhara Swamy Keshavapura
Koteswara Satya Vijaya Kumar Erra
Maniram Singh Kushwaha Manoj
Kota Sridevi
Raman Mythili
Dhananjay Tare Swati
Kumar Deshmukh Sunil
Schummer Dietmar
Kurz Michael
Kogler Herbert
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of TR200003570T2 publication Critical patent/TR200003570T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Mevcut bulus HIL-008003 (DSM 11641) mikroorganizmasinin kültürü vasitasiyla elde edilen Mumbaistatin adli bir bilesikle ve bu bilesigin farmasötik olarak uygun olan tuzlari ve türevleri ile ilgilidir. Mumbaistatin bir glikoz-6-fosfat translokaz önleyicisidir ve seker hastaliginin tedavisinde kullanilabilmektedir. Mevcut bulus ayrica Mumbaistatin'in üretimi için olan bir islem ile, HIL-008003 (DSM 11641) mikroorganizmasi ile, Mumbaistatin'in ve onun farmasötik olarak uygun olan tuzlarinin ve türevlerinin özellikle seker hastaliginin tedavisinde farmasötik maddeler olarak kullanilmalari ile ve Mumbaistatini ya da onun farmasötik olarak uygun olan bir tuzunu ya da türevini içeren farmasötik kompozisyonlar ile ilgilidir.
TR2000/03570T 1998-06-24 1999-06-15 Mumbaistatin, Üretim yöntemi ve farmasötik kullanımı TR200003570T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98111636 1998-06-24

Publications (1)

Publication Number Publication Date
TR200003570T2 true TR200003570T2 (tr) 2001-04-20

Family

ID=8232164

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03570T TR200003570T2 (tr) 1998-06-24 1999-06-15 Mumbaistatin, Üretim yöntemi ve farmasötik kullanımı

Country Status (17)

Country Link
US (1) US6297043B1 (tr)
EP (1) EP1090136B1 (tr)
JP (1) JP4287593B2 (tr)
KR (1) KR20010071564A (tr)
CN (1) CN1306580A (tr)
AR (1) AR020328A1 (tr)
AT (1) ATE328103T1 (tr)
AU (1) AU750509B2 (tr)
BR (1) BR9912200A (tr)
CA (1) CA2336135A1 (tr)
DE (1) DE69931633T2 (tr)
HU (1) HUP0102370A3 (tr)
ID (1) ID27411A (tr)
PL (1) PL345192A1 (tr)
RU (1) RU2221870C2 (tr)
TR (1) TR200003570T2 (tr)
WO (1) WO1999067408A1 (tr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS50431B (sr) * 1999-10-25 2009-12-31 Sanofi-Aventis Deutschland Gmbh., Derivati aromatičnih di-ketona, postupci za njihovu izradu i njihova upotreba kao farmaceutskih proizvoda
US7659102B2 (en) 2001-02-21 2010-02-09 Verenium Corporation Amylases, nucleic acids encoding them and methods for making and using them
WO2002068589A2 (en) 2001-02-21 2002-09-06 Diversa Corporation Enzymes having alpha amylase activity and methods of use thereof
WO2004042006A2 (en) 2002-10-31 2004-05-21 Diversa Corporation Amylases, nucleic acids encoding them and methods for making and using them
JP6465299B2 (ja) * 2015-05-29 2019-02-06 株式会社山田養蜂場本社 蜂蜜画分

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3905942A (en) 1973-06-22 1975-09-16 Gen Electric Method for making polyetherimides and products produced thereby
DE2429648A1 (de) * 1973-06-22 1975-01-16 Gen Electric Verfahren zum herstellen von polyaetherimiden

Also Published As

Publication number Publication date
ID27411A (id) 2001-04-05
EP1090136A1 (en) 2001-04-11
JP4287593B2 (ja) 2009-07-01
DE69931633D1 (de) 2006-07-06
US6297043B1 (en) 2001-10-02
CA2336135A1 (en) 1999-12-29
RU2221870C2 (ru) 2004-01-20
WO1999067408A1 (en) 1999-12-29
BR9912200A (pt) 2001-11-20
HUP0102370A3 (en) 2003-10-28
HUP0102370A2 (hu) 2001-10-28
EP1090136B1 (en) 2006-05-31
CN1306580A (zh) 2001-08-01
AR020328A1 (es) 2002-05-08
DE69931633T2 (de) 2007-05-10
JP2002518057A (ja) 2002-06-25
ATE328103T1 (de) 2006-06-15
KR20010071564A (ko) 2001-07-28
AU750509B2 (en) 2002-07-18
PL345192A1 (en) 2001-12-03
AU4513799A (en) 2000-01-10

Similar Documents

Publication Publication Date Title
UA44254C2 (uk) Похідні 4-(заміщеного феніламіно)хіназоліну, спосіб їх одержання, спосіб лікування і фармацевтична композиція
HUP0101146A2 (hu) Foszfolipáz enzim inhibitor hatású indolszármazékok, valamint a vegyületeket tartalmazó gyógyászati készítmények
AP9701039A0 (en) Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one.
TR199902203T2 (tr) Fernesil transferaz engelleyici, N-veya C-baglantili imidazoller ile ikame edilmis 1,8-anele kinolinon türevleri.
TR200401739T4 (tr) Persikuinnin, üretimi ve ilaç olarak kullanımı için bir işlem
ATE253545T1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
DK0889875T3 (da) Cycloproylalkansyrederivater
MY112413A (en) Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
DE69830504D1 (de) Antithrombotische mitteln
ES2132415T3 (es) Nuevos derivados de 5-pirrolil-2-piridilmetilsulfinilbencimidazol.
NO963370D0 (no) Nye mercaptoacetylamido-1,3,4,5-tetrahydro-benzo[cÅazepin-3-on-disulfidderivater som er anvendbare som inhibitorer av enkefalinase og ACE
ATE242206T1 (de) Substituierte derivate von benzosulphonamiden als hemmer des enzym cyclooxygenase ii
MY123908A (en) Meta-azacyclic amino benzoic acid compounds and derivatives thereof
YU41198A (sh) Derivati pirolopirolona kao inhibitori neutrofilne elastaze
AU2364000A (en) Heterocyclic amides as inhibitors of factor xa
HUP0001164A2 (hu) PF1022-ciklodepszipeptid-származékok
ATE60763T1 (de) Pyrrolidinylamidesterderivate mit antiprolylendopeptidaseaktivitaet, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische zubereitungen.
TR199700206A2 (tr) Floralkil- ve floralkoksi ikame edilmis heterosiklik bradikinin-antagonistleri, bunlarin imal edilmesine mahsus usul ve bunlarin kullanilmalari.
IT1256320B (it) Derivati eterociclici
TR200001909T2 (tr) Matris metaloprotez inhibitörleri.
TR200003570T2 (tr) Mumbaistatin, Üretim yöntemi ve farmasötik kullanımı
NO983444L (no) Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
TR200101279T2 (tr) Vankoremisin, üretimi için işlem ve farmatik olarak kullanımı
HUP9801925A1 (hu) Nátrium/hidrogén-csere inhibítorok alkalmazása protozoák által okozott betegségek kezelésére alkalmas gyógyszerkészítmények előállítására
YU43499A (sh) Kristalna hidratovana natrijumova so (e)-4,6-dihloro-3- (2-okso-1-fenilpirolidin-3-iliden metil)-1h-indol-2- karboksilne kiseline